Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factor‑κB signaling pathway

Liu,Jun; Liu,Yu; Ren,Yingang; Kang,Li; Zhang,Lihua

doi:10.3892/mmr.2014.1888

Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factor‑κB signaling pathway

Authors:
- Jun Liu
- Yu Liu
- Yingang Ren
- Li Kang
- Lihua Zhang
View Affiliations

Affiliations: Department of Geriatrics, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China, Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China
Published online on: January 8, 2014 https://doi.org/10.3892/mmr.2014.1888
Pages: 1068-1074

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ion channels have been suggested to be important in the development and progression of tumors, however, chloride channels have rarely been analyzed in tumorigenesis. More recently, transmembrane protein with unknown function 16A (TMEM16A), hypothesized to be a candidate calcium‑activated Cl‑ channel, has been found to be overexpressed in a number of tumor types. Although several studies have implicated the overexpression of TMEM16A in certain tumor types, the exact role of TMEM16A in gliomas and the underlying mechanisms in tumorigenesis, remain poorly understood. In the present study, the role of TMEM16A in gliomas and the potential underlying mechanisms were analyzed. TMEM16A was highly abundant in various grades of gliomas and cultured glioma cells. Knockdown of TMEM16A suppressed cell proliferation, migration and invasion. Furthermore, nuclear factor‑κB (NF‑κB) was activated by overexpression of TMEM16A. In addition, TMEM16A regulated the expression of NF‑κB‑mediated genes, including cyclin D1, cyclin E and c‑myc, involved in cell proliferation, and matrix metalloproteinases (MMPs)‑2 and MMP‑9, which are associated with the migration and invasion of glioma cells. Collectively, results of the present study provide evidence for the involvement of TMEM16A in gliomas and the potential mechanism through which TMEM16A promotes glioma formation.

View Figures

View References

1	Stühmer W, Alves F, Hartung F, Zientkowska M and Pardo LA: Potassium channels as tumour markers. FEBS Lett. 580:2850–2852. 2006.PubMed/NCBI
2	Lastraioli E, Taddei A, Messerini L, et al: hERG1 channels in human esophagus: evidence for their aberrant expression in the malignant progression of Barrett’s esophagus. J Cell Physiol. 209:398–404. 2006.PubMed/NCBI
3	Masi A, Becchetti A, Restano-Cassulini R, et al: hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines. Br J Cancer. 93:781–792. 2005. View Article : Google Scholar : PubMed/NCBI
4	Panner A and Wurster RD: T-type calcium channels and tumor proliferation. Cell Calcium. 40:253–259. 2006. View Article : Google Scholar : PubMed/NCBI
5	Diss JK, Stewart D, Pani F, et al: A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis. 8:266–273. 2005. View Article : Google Scholar : PubMed/NCBI
6	Fraser SP, Diss JK, Chioni AM, et al: Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res. 11:5381–5389. 2005. View Article : Google Scholar : PubMed/NCBI
7	Furst J, Gschwentner M, Ritter M, et al: Molecular and functional aspects of anionic channels activated during regulatory volume decrease in mammalian cells. Pflugers Arch. 444:1–25. 2002.PubMed/NCBI
8	Ferrera L, Caputo A and Galietta LJ: TMEM16A protein: a new identity for Ca(2+)-dependent Cl^- channels. Physiology (Bethesda). 25:357–363. 2010.
9	Hartzell C, Putzier I and Arreola J: Calcium-activated chloride channels. Annu Rev Physiol. 67:719–758. 2005. View Article : Google Scholar : PubMed/NCBI
10	Caputo A, Caci E, Ferrera L, et al: TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science. 322:590–594. 2008. View Article : Google Scholar : PubMed/NCBI
11	Yang YD, Cho H, Koo JY, et al: TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature. 455:1210–1215. 2008. View Article : Google Scholar : PubMed/NCBI
12	Schroeder BC, Cheng T, Jan YN and Jan LY: Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell. 134:1019–1029. 2008. View Article : Google Scholar : PubMed/NCBI
13	Rock JR, O’Neal WK, Gabriel SE, et al: Transmembrane protein 16A (TMEM16A) is a Ca²⁺-regulated Cl⁻ secretory channel in mouse airways. J Biol Chem. 284:14875–14880. 2009. View Article : Google Scholar : PubMed/NCBI
14	Huang F, Rock JR, Harfe BD, et al: Studies on expression and function of the TMEM16A calcium-activated chloride channel. Proc Natl Acad Sci USA. 106:21413–21418. 2009. View Article : Google Scholar : PubMed/NCBI
15	Hwang SJ, Blair PJ, Britton FC, et al: Expression of anoctamin 1/TMEM16A by interstitial cells of Cajal is fundamental for slow wave activity in gastrointestinal muscles. J Physiol. 587:4887–4904. 2009. View Article : Google Scholar : PubMed/NCBI
16	Romanenko VG, Catalán MA, Brown DA, et al: Tmem16A encodes the Ca²⁺-activated Cl⁻ channel in mouse submandibular salivary gland acinar cells. J Biol Chem. 285:12990–13001. 2010.PubMed/NCBI
17	Elble RC and Pauli BU: Tumor suppression by a proapoptotic calcium-activated chloride channel in mammary epithelium. J Biol Chem. 276:40510–40517. 2001. View Article : Google Scholar : PubMed/NCBI
18	Spitzner M, Martins JR, Soria RB, et al: Eag1 and Bestrophin 1 are up-regulated in fast-growing colonic cancer cells. J Biol Chem. 283:7421–7428. 2008. View Article : Google Scholar : PubMed/NCBI
19	Katoh M and Katoh M: FLJ10261 gene, located within the CCND1-EMS1 locus on human chromosome 11q13, encodes the eight-transmembrane protein homologous to C12orf3, C11orf25 and FLJ34272 gene products. Int J Oncol. 22:1375–1381. 2003.PubMed/NCBI
20	Akervall JA, Jin Y, Wennerberg JP, et al: Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer. 76:853–859. 1995. View Article : Google Scholar : PubMed/NCBI
21	Schwab M: Amplification of oncogenes in human cancer cells. Bioessays. 20:473–479. 1998. View Article : Google Scholar : PubMed/NCBI
22	Carles A, Millon R, Cromer A, et al: Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display. Oncogene. 25:1821–1831. 2006. View Article : Google Scholar : PubMed/NCBI
23	Espinosa I, Lee CH, Kim MK, et al: A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol. 32:210–218. 2008. View Article : Google Scholar : PubMed/NCBI
24	Kashyap MK, Marimuthu A, Kishore CJ, et al: Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther. 8:36–46. 2009. View Article : Google Scholar : PubMed/NCBI
25	Yang H, Huang LY, Zeng DY, et al: Decrease of intracellular chloride concentration promotes endothelial cell inflammation by activating nuclear factor-kappaB pathway. Hypertension. 60:1287–1293. 2012. View Article : Google Scholar : PubMed/NCBI
26	Chen J, Fok KL, Chen H, et al: Cryptorchidism-induced CFTR down-regulation results in disruption of testicular tight junctions through up-regulation of NF-κB/COX-2/PGE2. Hum Reprod. 27:2585–2597. 2012.PubMed/NCBI
27	He G, Ma Y, Chou SY, et al: Role of CLIC4 in the host innate responses to bacterial lipopolysaccharide. Eur J Immunol. 41:1221–1230. 2011. View Article : Google Scholar : PubMed/NCBI
28	Sheridan GK, Pickering M, Twomey C, et al: NF-kappaB activity in distinct neural subtypes of the rat hippocampus: Influence of time and GABA antagonism in acute slice preparations. Learn Mem. 14:525–532. 2007. View Article : Google Scholar : PubMed/NCBI
29	Miller FJ Jr, Filali M, Huss GJ, et al: Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ Res. 101:663–671. 2007. View Article : Google Scholar : PubMed/NCBI
30	Laver T, Nozell S and Benveniste EN: The NF-κB signaling pathway in GBMs: implications for apoptotic and inflammatory responses and exploitation for therapy. CNS Cancer: Models, Markers, Prognostic Factors, Targets and Therapeutic Approaches. Van Meir EG: 1. Humana Press (Springer); New York, NY: pp. 1011–1036. 2009
31	Gilmore TD: Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 25:6680–6684. 2006. View Article : Google Scholar : PubMed/NCBI
32	Perkins ND: The Rel/NF-kappa B family: friend and foe. Trends Biochem Sci. 25:434–440. 2000. View Article : Google Scholar : PubMed/NCBI
33	Perkins ND and Gilmore TD: Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ. 13:759–772. 2006. View Article : Google Scholar : PubMed/NCBI
34	Louis DN, Ohgaki H, Wiestler OD, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
35	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
36	Lee CH, Jeon YT, Kim SH and Song YS: NF-kappaB as a potential molecular target for cancer therapy. Biofactors. 29:19–35. 2007. View Article : Google Scholar : PubMed/NCBI
37	Sethi G, Sung B and Aggarwal BB: Nuclear factor-kappaB activation: from bench to bedside. Experiment Biol Med (Maywood). 233:21–31. 2008. View Article : Google Scholar : PubMed/NCBI
38	Van Waes C: Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res. 13:1076–1082. 2007.PubMed/NCBI
39	Bauvois B: New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta. 1825:29–36. 2012.PubMed/NCBI
40	Veeravalli KK and Rao JS: MMP-9 and uPAR regulated glioma cell migration. Cell Adh Migr. 6:509–512. 2012. View Article : Google Scholar : PubMed/NCBI
41	Kesanakurti D, Chetty C, Rajasekhar Maddirela D, Gujrati M and Rao JS: Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma. Cell Death Dis. 3:e4452012. View Article : Google Scholar : PubMed/NCBI
42	Habela CW, Ernest NJ, Swindall AF and Sontheimer H: Chloride accumulation drives volume dynamics underlying cell proliferation and migration. J Neurophysiol. 101:750–757. 2009.PubMed/NCBI
43	Habela CW, Olsen ML and Sontheimer H: ClC3 is a critical regulator of the cell cycle in normal and malignant glial cells. J Neurosci. 28:9205–9217. 2008. View Article : Google Scholar : PubMed/NCBI
44	Kunzelmann K, Kongsuphol P, Aldehni F, et al: Bestrophin and TMEM16-Ca(2+) activated Cl(−) channels with different functions. Cell Calcium. 46:233–241. 2009.PubMed/NCBI
45	Ayoub C, Wasylyk C, Li Y, et al: ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines. Br J Cancer. 103:715–726. 2010. View Article : Google Scholar : PubMed/NCBI
46	Duvvuri U, Shiwarski DJ, Xiao D, et al: TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res. 72:3270–3281. 2012. View Article : Google Scholar : PubMed/NCBI
47	Simon S, Grabellus F, Ferrera L, et al: DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors. Cancer Res. 73:3661–3670. 2013. View Article : Google Scholar : PubMed/NCBI
48	Mazzone A, Eisenman ST, Strege PR, et al: Inhibition of cell proliferation by a selective inhibitor of the Ca(2+)-activated Cl(−) channel, Ano1. Biochem Biophys Res Commun. 427:248–253. 2012.
49	Liu W, Lu M, Liu B, Huang Y and Wang K: Inhibition of Ca(2+)-activated Cl(−) channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma. Cancer Lett. 326:41–51. 2012.
50	Abdullah JM, Ahmad F, Ahmad KA, et al: Molecular genetic analysis of BAX and Cyclin D1 genes in patients with malignant glioma. Neurol Res. 29:239–242. 2007. View Article : Google Scholar : PubMed/NCBI
51	Arato-Ohshima T and Sawa H: Over-expression of cyclin D1 induces glioma invasion by increasing matrix metalloproteinase activity and cell motility. Int J Cancer. 83:387–392. 1999. View Article : Google Scholar : PubMed/NCBI
52	Zhang X, Zhao M, Huang AY, et al: The effect of cyclin D expression on cell proliferation in human gliomas. J Clin Neurosci. 12:166–168. 2005. View Article : Google Scholar : PubMed/NCBI
53	Liao DJ, Thakur A, Wu J, Biliran H and Sarkar FH: Perspectives on c-Myc, cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. Crit Rev Oncogen. 13:93–158. 2007. View Article : Google Scholar : PubMed/NCBI
54	Robson S, Pelengaris S and Khan M: c-Myc and downstream targets in the pathogenesis and treatment of cancer. Recent Pat Anticancer Drug Discov. 1:305–326. 2006. View Article : Google Scholar : PubMed/NCBI